TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 59 filers reported holding TALARIS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,092,759 | -2.0% | 1,100,626 | +6.0% | 0.00% | – |
| Q2 2023 | $3,155,128 | +49.2% | 1,037,871 | -7.7% | 0.00% | – |
| Q1 2023 | $2,114,900 | +97.1% | 1,124,947 | +7.0% | 0.00% | – |
| Q4 2022 | $1,072,848 | -59.9% | 1,051,811 | +3.4% | 0.00% | – |
| Q3 2022 | $2,675,000 | -41.7% | 1,016,998 | -0.1% | 0.00% | – |
| Q2 2022 | $4,591,000 | -54.7% | 1,018,125 | -1.2% | 0.00% | – |
| Q1 2022 | $10,142,000 | -35.7% | 1,030,742 | -0.0% | 0.00% | – |
| Q4 2021 | $15,761,000 | +194.9% | 1,030,822 | +161.5% | 0.00% | – |
| Q3 2021 | $5,345,000 | -6.9% | 394,178 | +0.9% | 0.00% | – |
| Q2 2021 | $5,741,000 | – | 390,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $8,240,623 | 10.94% |
| BML Capital Management, LLC | 2,000,000 | $5,620,000 | 5.16% |
| Nantahala Capital Management | 2,953,129 | $8,298,292 | 0.71% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $2,810,000 | 0.51% |
| Acuitas Investments, LLC | 194,547 | $546,677 | 0.32% |
| Affinity Asset Advisors, LLC | 400,000 | $1,124,000 | 0.32% |
| RA Capital Management | 2,403,238 | $6,753,099 | 0.13% |
| Artal Group S.A. | 914,262 | $2,569 | 0.11% |
| Blackstone Inc. | 8,089,315 | $22,730,975 | 0.10% |
| QVT Financial LP | 589,314 | $1,655,972 | 0.09% |